Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 8
Submit an article Journal homepage
322
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Isolated neutropenia during ABVD chemotherapy for Hodgkin lymphoma does not require growth factor support

Dr. Jyoti Nangalia Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UKCorrespondence[email protected]
,
Hannah Smith Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK
&
Jennie Z. Wimperis Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK
Pages 1530-1536 | Received 06 Apr 2008, Accepted 17 May 2008, Published online: 01 Jul 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

M. C. Cheung, A. Prica, J. Graczyk, R. Buckstein & K. K. W. Chan. (2016) Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis. Leukemia & Lymphoma 57:8, pages 1865-1875.
Read now
Joanna Graczyk, Matthew C. Cheung, Rena Buckstein & Kelvin Chan. (2014) Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysis. Leukemia & Lymphoma 55:1, pages 56-62.
Read now
Leonard A. Minuk, Katherine Monkman, Ian H. Chin-Yee, Alejandro Lazo-Langner, Vinai Bhagirath, Benjamin H. Chin-Yee & Joy E. Mangel. (2012) Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study. Leukemia & Lymphoma 53:1, pages 57-63.
Read now

Articles from other publishers (8)

Cumali YALÇIN, Aslan ERDOĞAN & Güven YILMAZ. (2023) What is the main reason of erectile dysfunction in lymphoma patients: Chemotherapy or Depression?. Turkish Journal of Internal Medicine 5:2, pages 77-83.
Crossref
Seyed Mahdi Seyedzadeh Sani, Mehrdad Sahranavard, Mahdi Jannati Yazdanabad, Mohsen Seddigh Shamsi, Sepideh Elyasi, Amir Hooshang Mohammadpour, Thozhukat Sathyapalan, Omid Arasteh, Vahid Ghavami & Amirhossein Sahebkar. (2022) The effect of concomitant use of Colony-Stimulating factors on bleomycin pulmonary toxicity – A systematic review and meta-analysis. International Immunopharmacology 112, pages 109227.
Crossref
P. V. Datsenko. (2016) Lymphocyte lineage and hematological toxicity in Hodgkin?s lymphoma. Onkologiya. Zhurnal imeni P.A.Gertsena 5:6, pages 54.
Crossref
George A. Follows, Kirit M. Ardeshna, Sally F. Barrington, Dominic J. Culligan, Peter J. Hoskin, David Linch, Shalal Sadullah, Michael V. Williams & Jennifer Z. Wimperis. (2014) Guidelines for the first line management of classical Hodgkin lymphoma. British Journal of Haematology 166:1, pages 34-49.
Crossref
Prahlad Ho, Peter Sherman & Andrew Grigg. (2012) Intermittent granulocyte colony‐stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia. European Journal of Haematology 88:5, pages 416-421.
Crossref
D. J. Straus. (2011) Chemotherapy only for localized Hodgkin lymphoma. Journal of Internal Medicine 270:3, pages 197-205.
Crossref
Bhanu Vakkalanka & Brian K. Link. (2011) Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma. Advances in Hematology 2011, pages 1-7.
Crossref
David J. Straus. (2009) The Case for Chemotherapy Only for Localized Hodgkin Lymphoma. The Oncologist 14:12, pages 1225-1231.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.